India’s National AIDS Control Programme Reversing the Tide International AIDS Conference Washington D.C., U.S.A July 2012 Aradhana Johri Additional Secretary, National AIDS Control Organization Government of India 1
Feb 22, 2016
India’s National AIDS Control Programme
Reversing the Tide
International AIDS ConferenceWashington D.C., U.S.A
July 2012
Aradhana JohriAdditional Secretary,
National AIDS Control OrganizationGovernment of India
1
Reversal of the Epidemic
The Route
Looking Forward
1
2
3
Today’s Agenda
2
0.31% adults infected2.3 million people living with HIV
20-25 million people projected to be living with AIDS by 2010 (highest number in any country in the world)
Early 2000’s….projections Today…
0tan22a566522
0tan23a566523
0tan24a566524
0tan25a566525
0tan26a566526
0tan27a566527
48tan28a566028
12tan28a566028
48tan28a566028
24tan28a56602824tan28a566028
48tan28a566028
Age
-adj
uste
d H
IV p
reva
lenc
e (%
)
Source: HIV Estimations, 2010 & NACO’s ANC Sentinel Surveillance data. Consistent ANC sites for the age group 15-24 were analysed
Source: National Intelligence Council (2002) 'The Next wave of HIV/AIDS: Nigeria, Ethiopia, Russia, India and China', September, p.3
56% reduction
in new infections over the
last decade!
HIV in India...grim projections earlier, but a global success story today
3
Reduced Deaths & More Efficient Case Detection
123463142782
160861176968
189872 196466 199502 193257 185870172041
684528177
64116
134928
217781
375204
0
50000
100000
150000
200000
250000
300000
350000
400000
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Annual Deaths Pts. On ART
Decline in estimated annual AIDS-related deaths with scale-up of ART
Declining AIDS-
related deaths
Significant increase in
baseline CD4 count
at detection
4
Source: HIV Estimations, 2010
The Road Map
NACP I (1994-1999)Initial
Interventions
NACP II (1999-2006)
-Decentralisation to states - Limited
coverage of services
NACP III (2007-2012)
Massive scale up with quality assurance
mechanisms 56% reduction
in new infections achieved
NACP IV (2013+)
Consolidate gains
Focus on MARPSQuality
assurance5
Quadrupling of budget for HIV under NACP III ($ Million)…
1990
-199
2
1992
-199
9
1999
- 20
04;
exte
nded
to
2007
2007
-201
2
Medium term plan NACP I NACP II NACP III
- 200 400 600 800
1,000 1,200 1,400 1,600 1,800 2,000
4 113
459
1,783
Additional 800m of extra budgetary support
6
0tan26a566526 0tan1a566510tan28a566028
0tan21a566021
0tan14a566114
0tan7a56617
0tan1a56621
0tan24a566224
0tan17a566317
0tan10a566410
0tan4a56644
0tan26a566526
0tan28a566028
0tan9a56609
0tan19a566019
0tan29a566029
0tan9a56609
0tan19a566019
0tan29a566029
0tan9a56609
0tan19a566019
0tan29a566029
0tan10a566010
0tan9a56629
0tan17a566517
0tan29a566029
0tan19a566019
Targeted Interventions
No. of Tis % Coverage of MARPS
No.
of T
Is
% C
over
age
of M
ARPS
Ambitious Targets, Impressive
Achievements
7
0tan26a566526 0tan1a566510tan28a566028
0tan21a566021
0tan14a566114
0tan7a56617
0tan1a56621
0tan24a566224
0tan17a566317
0tan28a566028
0tan1a56601
0tan3a56603
0tan5a56605
0tan7a56607
0tan9a56609
0tan11a566011
0tan17a566217
0tan17a566317
0tan1a56601
0tan9a56609
STI/ RTI Services
No. of STI CentresSTI episodes treated annually (Millions)
No.
of S
TI C
entr
es
STI e
piso
des t
reat
ed a
nnua
lly (M
illio
ns)
8
Ambitious Targets, Impressive
Achievements
0tan27a566527 0tan1a566510tan28a566028
0tan19a566019
0tan10a566010
0tan1a56601
0tan21a566021
0tan12a566012
0tan3a56613
0tan23a566123
0tan14a566114
0tan28a566028
0tan19a566019
0tan10a566010
0tan1a56601
0tan21a566021
0tan12a566012
0tan3a56613
0tan23a566123
0tan14a566114
0tan5a56615
0tan25a566125
0tan15a566015
0tan12a566112
0tan21a566021
0tan27a566127
Condom Social Marketing
No. of Districts with CSMPCondom Sales (Millions)
No.
of D
istr
icts
with
CSM
P
No.
of C
ondo
ms D
istr
. (M
illio
ns)
9
Ambitious Targets, Impressive
Achievements
10
Ambitious Targets, Impressive
Achievements
0tan26a566526
0tan1a566510tan28a566028
0tan19a566519
0tan12a567112
0tan3a56763
0tan24a568224
0tan16a568716
0tan8a56938
0tan28a566028
0tan4a56604
0tan9a56609
0tan14a566014
0tan19a566019
0tan24a566024
0tan29a566029
0tan26a567126
0tan3a56753
0tan24a567324
0tan4a56604
0tan18a566018
HIV Counseling & Testing Services
No. of Stand-alone ICTCNo. of FICTCNo. Tested Annually (Million)
No.
of I
CTCs
No.
Tes
ted
Annu
ally
(Mill
ions
)
10,515
0tan26a566526
0tan1a56651 -
01
02
03
04
05
06
07
08
09
10
0tan16a568716
0tan15a568915
0tan13a569013
0tan11a569111
0tan8a56938
0tan6a56946
0tan5a56955
0tan2a56972
02
09 11,460
13,013
PPTCT Programme
No. of Pregnant Women tested (million)No. of MB Pairs Received NVP
No.
of P
regn
ant W
omen
Tes
ted
(mill
ion)
No.
MB
Pairs
Rec
d. N
VP
11
Ambitious Targets, Impressive
Achievements
0tan26a566526 0tan1a566510tan28a566028
0tan21a566021
0tan14a566114
0tan7a56617
0tan1a56621
0tan24a566224
0tan17a566317
0tan28a566028
0tan10a566010
0tan21a566021
0tan3a56613
0tan14a566114
0tan25a566125
0tan7a56617
0tan7a56607
0tan28a566128
0tan15a566215
0tan8a56608
0tan12a566112
Anti-Retroviral Treatment (ART)
No. of ART CentresNo. of Link ART CentresNo. of PLHIV on ART ('000)
No.
of A
RT C
entr
es
No.
of P
LHIV
on
ART
(‘000
)
12
Ambitious Targets, Impressive
Achievements
TG IDU MSM FSW Truckers Migrants ANC0
1
2
3
4
5
6
7
8
9
10
8.824
7.170
4.430
2.670 2.592
.986.415
HIV Prevalence (%)
Source: 2010-11 NACO HIV Sentinel Surveillance – Provisional Findings
13
India continues to portray
a concentra
ted epidemic
New Evidence…HSS 2010-11
New Evidence…HSS 2010-11
03-05 04-06 05-07 06-08 07-100tan3a56603
0tan4a56604
0tan5a56605
0tan6a56606
0tan7a56607
0tan8a56608
0tan9a56609
0tan10a566010
0tan28a566028
0tan28a566028
0tan29a566029
IDU FSW MSM ANC
ANC
HIV
Prev
alen
ce (%
)
Declining trends at national level among general
population, FSW & MSM
Stable trends at national level
among IDU
Need to study trends among
Migrants, Truckers and TG
Source: 2010-11 NACO HIV Sentinel Surveillance – Provisional FindingsNote: 3-yr moving averages based on consistent sites; ANC–385 sites, FSW–89 sites, MSM–22 sites, IDU–38 sites 14
Further decline in HIV prevalence among different risk groups
ANC
IDU
FSW
MSM
HIV Epidemics among FSW
States with higher vulnerability among FSW
Declining trends among FSW at national level and in all the states
Greater need to sustain the reach and quality of FSW interventions to consolidate the gains
Vulnerability due to FSW also extends to source states for migration
Large size of FSW with higher HIV prevalence in high prevalence states
Source: NACO HIV Sentinel Surveillance 2010-11 – Provisional Findings; NACO Mapping of HRG 2008-09;
HIV Epidemics among MSM
States with higher vulnerability among MSM
Large size and higher levels of HIV among MSM in high prevalence states and low prevalence states of Gujarat, MP, West Bengal, Chhattisgarh, Delhi etc.Need to saturate coverage among MSM through effective prevention services
Source: NACO HIV Sentinel Surveillance 2010-11 – Provisional Findings; NACO Mapping of HRG 2008-09;
HIV Epidemics among IDU
States with higher vulnerability among IDU
Higher levels of HIV among IDU in Punjab, Chandigarh, Delhi and Mumbai, in addition to North EastEmerging epidemics among IDUs in low prevalence states of Kerala, Orissa, MP, Bihar and UPFocus on saturation with Needle-Syringe Exchange Programme and Scale-up of OST
Source: NACO HIV Sentinel Surveillance 2010-11 – Provisional Findings; NACO Mapping of HRG 2008-09;
HIV Epidemics due to Migration
States with higher vulnerability due to Migration
Rising trends in low prevalence states among ANC attendees despite low level, stable epidemics among HRG in these states
Mapped migration corridors with large volumes of out-migration to high prevalence destinations
HIV prevalence – higher among rural ANC than urban; higher among those whose spouse is a migrant
Need to increase coverage of migrants at destinations & along with their spouses at source
Source: NACO HIV Sentinel Surveillance 2010-11 – Provisional Findings; Source: Population Council Study -- Reference: Saggurti N, Mahapatra BB, Swain SN, Jain AK. Male out-migration and sexual risk behavior in India: Is the place of origin critical for HIV prevention programs?. BMC Public Health. 2011. 11:S6;
Emerging Vulnerabilities
Jharkhand
Maharashtra
Tamil Nadu
Madhya Pradesh
Average
Gujarat
Andhra Pradesh
Karnataka
West Bengal
0tan28a566028 0tan1a56601 0tan3a56603
001
002
002
002
003
003
003
003
004HIV Prevalence (%) among Truckers
Mumbai
Chennai
Average
0tan28a566028 0tan9a56609 0tan19a566019
019
004
009
HIV Prevalence (%) among TGs
Greater vulnerability among Truckers and Trans-gendersNeed to generate more evidence on epidemic trends and transmission dynamicsNeed to scale up and strengthen prevention interventions for Truckers & TG
Source: 2010-11 NACO HIV Sentinel Surveillance – Provisional Findings
TRUCKERS TRANS-GENDERS (TGs)
Targeted Interventions Proven Cost-Effective
Characteristic Value
Cumulative Costs of implementing FSW TI (1995-2015)
USD 1991 Million
Cumulative HIV infections averted by FSW TIs (1995-2015)
2.7 Million
Cost per HIV infection averted
USD 105.5
Cost per DALY averted USD 10.9
Districts with higher TI intervention intensity show greater declines than those with lower TI intensity2.7 million lives saved through TIs, cost of ~$100/ infection averted
Source: Impact of Targeted Interventions on Heterosexual Transmission of HIV in India, Kumar R, Mehendale SM, Panda S; Sex Transm Infect 2011;87:354e361. doi:10.1136/sti.2010.047829, Prinja et al
20
HIV prevalence according to TI intensity among young ANC attendees (15-24 yrs) in Tamil Nadu, Karnataka,
Maharashtra and Andhra Pradesh, India.
0.00
0.25
0.50
0.75
1.00
1.25
1.50
1.75
2.00
2.25
2001 2002 2003 2004 2005 2006 2007 2008
% H
IV p
reva
lenc
e
High TI intensity districts Low TI intensity districts
Reversal of the Epidemic
The Route
Looking Forward
1
2
3
Today’s Agenda
21
Guiding Principles
22
COMMUNITY and high risk groups at centre
PREVENTION focused
Increased access to
TREATMENT, care and support
Expanded service delivery
with AMBITIOUS TARGETS
The Route
Consultative
processManagement focus
Listening to data – Real time
23
Consultative process for planning and implementation
A community-centric approach
Communities of
MARPS and PLHIV
Technical experts
and resource groups
Civil Society
Development
Partners
Other governme
nt departme
nts
24
The Route
Consultative
processManagement focus
Listening to data – Real time
25
Leveraging Expertise
Guidelines, policy & planning
Fund release,
administration,
programme implementat
ion
Managing in-sourced units, coordinating
technical inputs
Technical inputs into
guideline and tool
development
Supportive
supervision --
‘feel on the
street’ quality
assuranceIn-sourced supportGovernment programme delivered
Core capabilities of government• Build on core health systems capabilities• Supplement with technical staff on contract• Partner with SACS• Contracts with management agencies
Leveraging external skills through:• Technical Resource
Groups• Technical Support Units• Academic partnerships
26Resulting in large improvements in service delivery… Eg: TI
Management Focus…
Standardization for scaleSome Examples…
27
Operational &
Technical Guideline
s
Uniform Training Modules
Structured
Monitoring
Mechanisms
Unit Costing
for Intervent
ions
Management Focus…
PHASE-1 (2007)• Focus on outreach• No services
PHASE-2 (2010)• Addition of services (Counseling & testing)
• Convergence with the health system• External Evaluation
PHASE-3 (2012)• Focus on Knowledge of HIV Services & Vulnerabilities – Youth & Migration
• Convergence and outreach strengthened; Greater focus on mid-media, folk arts, bus campaigns etc.
• Day-to-day monitoring, Pre-Post & Concurrent Evaluation
Flexible Modeling-Greater ImpactEg. Red Ribbon Express
28
RRE-1 RRE-2 RRE-30tan28a566028
0tan1a566010tan3a566030tan5a566050tan7a566070tan9a56609
0tan11a5660110tan13a5660130tan15a566015
0tan5a56605
0tan7a56607
0tan5a56605
0tan6a56606
Reach of RRE
No. of People Reached (Million)Projected
0tan28a566028
0tan19a566019
0tan9a56609
0tan29a566029
0tan19a566019
0tan10a566010
0tan30a566030 % of People who know at least 2 modes of HIV Transmission
Pre-RRE Post-RRE
The Route
Consultative
processManagement focus
Listening to data – Real time
29
Evidence-driven recasting of Migrant Strategy
Higher HIV Prevalence among Pregnant Women with a Migrant Spouse
Migrants over-represented (80%) among HIV+ men (Ganjam)
…resulting in re-scoping and
reshaping of Migrant Strategy under NACP-
III
Adding transit
and source interventions
to migrant packag
e
Tracking
migrant routes
for better focus
Reverse mappin
g to identify sources
and address spouses
of migrant
s
Source: Population Council Study -- Reference: Saggurti N, Mahapatra BB, Swain SN, Jain AK. Male out-migration and sexual risk behavior in India: Is the place of origin critical for HIV prevention programs?. BMC Public Health. 2011. 11:S6; NACO HIV Sentinel Surveillance
Linkages
between source
& destinat
ion
30
RAJ UP BIH WB JHAR ORI CHHT MP.000
.200
.400
.600
.800
1.000
1.200
Migrant Non-Migrant
HIV Positive Cases HIV Negative Controls0%
10%20%30%40%50%60%70%80%90%
100%
0tan18a566018
0tan24a566024
0tan21a566021
0tan17a566017
0tan26a566026
0tan24a566024
Non-Migrants Returned Migrants Active Migrants
Roll out of OST ProgrammeSetting up of Link ART Centres
0tan21a566021
0tan21a5660210tan5a5660
50tan7a5660
7
Proven impact of OST on reduced HIV risk
BaselineAfter OST
31
0tan28a566028 0tan19a566019 0tan9a56609
0tan4a56604
0tan5a56605
0tan12a566012
0tan1a56601
Percentage
Patients who travel >100 Kms/visit
Patients who don’t come to ARTC due to long distance
Patients who spend > Rs.100 / visit
Patients who don’t come due to finan. reason
Setting up of Link ART Centres
9
Monitoring of PLHA on ART
Screening of HIV TB Coinfection
Enrollment of PLHA in HIV Care and basic investigations
Pre-ART Management
Treatment of OIs
Psycho–socialSupport to PLHA
LAC
2010 2012 2014*0tan28a566028
0tan19a566019
0tan10a566010
0tan1a56601
0tan21a566021
0tan28a566028
0tan6a56736
0tan16a568716
0tan25a570125
0tan6a57156
0tan15a572815
0tan21a566021
0tan18a566018
0tan21a566021
0tan13a5673130tan22a567922
0tan6a57156
Scale-up of OST
No of OST CentresIDUs on OST
* Projected as per scale-up plan
OR to study Factors affecting ART Adherence
Evidence Led…
Reversal of the Epidemic
The Route
Looking Forward
1
2
3
Today’s Agenda
32
Challenges and the way forwardHigher
domestic funding
Balancing prevention
and treatment
Convergence with health system
Progressive policy
initiatives
Maintaining political
will
33
1. Increased reliance on domestic financing in view of dwindling donor
resources
Domestic Budget; 006
External Aided Component; 094
NACP-III
Domestic Budget; 077
External Aided Component; 023
2012-13
NACP-III: Expenditure till 31.03.2012; 2012-13: Budget Estimate
2. Balancing Prevention & TreatmentSTI
PPTCT / ICTC
Condom Promotion
MARPS
HIV-TB
Treatment of OIs
EID & Pediatric ART
Free First & Second Line ART
Sustaining Prevention Focus & Addressing Emerging Epidemics
Vs
Growing need for ART
3. Convergence for Higher Impact
-
1,000,000 272,263
585,459 803,551 812,743 242,021
568,430 796,667 797,291 PPTCT Scale up in Karnataka
No. of ANCs registered No. of ANCs tested for HIVSource: NACO-CMIS
ICTC, PPTCT, STI,
Blood Safety,
Condom
MARPS, ART
Social Protection
IEC
CHALLENGESCompeting priorities at state level Scaling up integration initiativesEnsuring availability of trained counselors / staffStigma in health care settings
Launch of PMTCT integration – mid-
2008
Complete integration
Partial integration
Coordination
Value addition / linkages
4. Taking the lead…Policy Initiatives
Mainstreaming harm reduction policy for
IDUs
Decriminalizing
homosexuality
Roll out of more
efficacious regimen
(Option-B) for PPTCT
Scale up of free Second
Line ART
37
“Some of the key priority areas will be preventing new infections in hitherto low prevalence states while consolidating efforts in the high prevalence states”The Prime Minister, Dr. Manmohan Singh, at the Parliamentary Forum on HIV/AIDS, 2011
5. Sustained political will
38
You must be the change you wish to see in the world…
-- Mahatma Gandhi
39
Thank You!and we march on…
40
Resulting in large improvements in TI service delivery levels
2010 2011 GrowthCore groups
attending STI clinics
2.3 mn 2.7 mn 16%
Core groups tested for HIV 0.8 mn 1.1 mn 35%
Condoms distributed to core groups
282 mn 298 mn 6%
Needle/syringe distribution to
IDUs44.5 mn 56.4 mn 27%
41